Abstract:Objective To investigate the effect of venlafaxine on the depression-like behavior, and the expression of CNPase, MBP and Nrg1 Ⅲ-ErbB2 expression in prefrontal cortex（PFC） of cuprizone（CPZ） treated mice. Methods A total of 32 C57BL/6 male mice aged 8-weeks were randomly divided into control group, venlafaxine（Ven） group, model（CPZ） group and CPZ+Ven group. Mice in CPZ and CPZ+Ven groups were fed with diet containing 0.2% CPZ for 5 weeks to establish CPZ model. Ven and CPZ+Ven groups received 20 mg/（kg·d） venlafaxine by gavage for 5 weeks. Control group and CPZ group were gavaged with 200 μl saline every day during the same time period. Open field experiment, sugar-water preference experiment and tail suspension experiment were carried out after 5-week intervention, and then 5 mice in each group were killed immediately. PFC was collected in liquid nitrogen. The protein levels of CNPase and MBP in PFC were detected by Western blot, and the level of Nrg1 Ⅲ-ErbB2 mRNA was detected by RT-PCR. The remaining mice（n=3） were perfused and fixed with 4% PFA,and then the morphological changes of oligodendrocytes were observed by immunofluorescence staining for CNPase. Results The total distance traveled in open field and distance of central movement of CPZ group were shorter than those of the control group [（12.50±4.73） m vs（25.63±5.64） m,（5.92±1.98） % vs（11.78±4.17） %]. The immobility time of suspended tail test was longer than that of the control group [（153.75±26.4） s vs（71.62±20.95） s]. Sugar preference index was lower than that of the control group [（79.16±6.53） % vs（92.67±2.97） %]. The protein expression levels of CNPase and MBP in PFC were lower than those of the control group [（0.56±0.08） vs（0.85±0.13）,（0.37±0.05） vs（1.01±0.08）]. The mRNA levels of Nrg1Ⅲ and ErbB2 were lower than those of the control group [（0.38±0.27） vs（1.06±0.16）,（0.42±0.41） vs（1.01±0.01）]. The differences of all the above were statistically significant（P ＜ 0.05）. The total distance traveled in open field and distance of central movement of CPZ+Ven group were longer than those of the CPZ group [（22.64±6.59） m vs（12.50±4.73） m,（10.6±2.85） % vs（5.92±1.98） %]. The immobility time of suspended tail test was longer than that of the CPZ group [（109.25±35.69） s vs（153.75±26.4） s].Sugar preference index was lower than that of the CPZ group [（91.63±2.98） % vs（79.16±6.53） %]. The protein expression levels of CNPase and MBP in PFC were lower than those of the CPZ group [（0.84±0.09） vs（0.56±0.08）,（0.71±0.13） vs（0.37±0.05）]. The mRNA levels of Nrg1Ⅲ and ErbB2 were lower than those of the CPZ group [（0.70±0.33） vs（0.38±0.27）,（0.80±0.25） vs（0.42±0.41）]. The differences of all the above were statistically significant（P ＜ 0.05）. CNPase immunofluorescence staining showed that there were fewer CNPase oligodendrocytes in the PFC of mice in the CPZ group than in the control group and the CPZ+Ven group.Conclusions Venlafaxine can up-regulate the levels of CNPase and MBP protein and the mRNA levels of Nrg1Ⅲ and ErbB2 in the PFC of CPZ mice,increase the number of oligodendrocytes,and alleviate depressionlike behaviors.

Effects of Quetiapine on the Memory and the Expression of Doublecortin in the Hippocampus of Schizophrenia Model Mice Induced by Cuprizone

The impact of quetiapine on the brain lipidome in a cuprizone-induced mouse model of schizophrenia

The Effects of Quetiapine on the Improvement of Behavior and Expression of Perk1/2 in the Hippocampus of Chronic Unpredictable Stress Model Rats

Quetiapine Alleviates the Cuprizone-Induced White Matter Pathology in the Brain of C57BL/6 Mouse

Quetiapine Enhances Oligodendrocyte Regeneration and Myelin Repair after Cuprizone-Induced Demyelination

Quetiapine attenuates spatial memory impairment and hippocampal neurodegeneration induced by bilateral common carotid artery occlusion in mice.

Quetiapine Inhibits Microglial Activation by Neutralizing Abnormal STIM1-Mediated Intercellular Calcium Homeostasis and Promotes Myelin Repair in a Cuprizone-Induced Mouse Model of Demyelination.

Quetiapine Ameliorates Schizophrenia-Like Behaviors and Protects Myelin Integrity in Cuprizone Intoxicated Mice: The Involvement of Notch Signaling Pathway

Quetiapine Attenuates the Depressive and Anxiolytic-Like Behavioural Changes Induced by Global Cerebral Ischemia in Mice

Quercetin ameliorates memory impairment by inhibiting abnormal microglial activation in a mouse model of paradoxical sleep deprivation

Region-specific Susceptibilities to Cuprizone-Induced Lesions in the Mouse Forebrain: Implications for the Pathophysiology of Schizophrenia.

The Therapeutic Effect of Quetiapine on Cognitive Impairment Associated with 5-HT1A Presynaptic Receptor Involved Schizophrenia

Quercetin attenuates brain apoptosis in mice with chronic unpredictable mild stress-induced depression

Behavioral and neurobiological changes in a novel mouse model of schizophrenia induced by the combination of cuprizone and MK-801

P4-230: A Novel Cognitive Enhancer Rescues Olfactory Bulbectomy-Induced Memory Impairment Through Stimulation of CaMKII and PKC Signalings in Mouse Hippocampus

Modulating NMDA receptors to treat MK-801-induced schizophrenic cognition deficit: effects of clozapine combining with PQQ treatment and possible mechanisms of action

Different doses of cuprizone induce mice behavior alterations and changes of myelinated nerve fibers in hippocampal CA1 and DG regions

Spiro[imidazo[1,2-a]pyridine-3,2-indan]-2(3H)-one (ZSET1446/ST101) Treatment Rescues Olfactory Bulbectomy-Induced Memory Impairment by Activating Ca2+/Calmodulin Kinase II and Protein Kinase C in Mouse Hippocampus

Effect of zinc chelating agent on the behaviors and hippocampus neurons of pilocarpine-induced epilepsy mice

Effects of venlafaxine on depression-like behavior and myelin damage and expression of Nrg1 Ⅲ-ErbB2 of prefrontal cortex in cuprizone-treated mice

NEP1-40 Alleviates Behavioral Phenotypes and Promote Oligodendrocyte Progenitor Cell Differentiation in the Hippocampus of Cuprizone-Induced Demyelination Mouse Model.